Olitigaltin

N/A

Report date: 2023/08/18 16:52:22
NME

Base Information

Drug NameOlitigaltin
Drug Alias NameTD-139GB-0139
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalectin-1 inhibitorsAngiogenesis inhibitorsGalectin-3 inhibitors
TargetsGalectin-3Galectin-1
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Idiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[15] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLund University FoundationThe University Of Edinburgh
China Registration ClassN/A

Develop Information

Active CompaniesGalecto Biotech ABThe University Of Edinburgh
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Idiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksKEGG